JUVMO
Active substance: tavapadon
TABLET · TAVAPADON 15 mg/1
United StatesActive
Marketing holder: AbbVie Inc.
Verified 2026-10-09 · openFDA NDC
- Source: openFDA NDC
- Countries with the substance registered: 1
Composition
- TAVAPADON · 15 mg/1
Import and control
Control by country
- United Statesprescription only
Source: openFDA NDC · record 01a1208c-4692-70e2-924e-db26ab0f9bab,01a1208c-f6f2-70e3-b450-a64f78049c53,01a1208d-fc9f-75bd-b736-ea16b871eb0e,01a12091-69ca-777b-8442-e5f84c494ecf,01a12095-6b69-7635-b088-dca4512e5d47;count=5 · valid from 2026-10-09 · verified 2026-10-09
Registration
- Registration number
- 0074-6315
- Registration status
- Active
- Dispensing
- Prescription only
- Route
- ORAL
Sources
- product · openFDA NDC · 0074-6315 · Verified 2026-10-09 · open in source
- registration_status · openFDA NDC · 0074-6315 · Verified 2026-10-09 · open in source
- ingredients.0 · openFDA NDC · 0074-6315 · Verified 2026-10-09 · open in source